Correlation Between Microsoft and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Microsoft and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Purple Biotech, you can compare the effects of market volatilities on Microsoft and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Purple Biotech.
Diversification Opportunities for Microsoft and Purple Biotech
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Microsoft and Purple is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Microsoft i.e., Microsoft and Purple Biotech go up and down completely randomly.
Pair Corralation between Microsoft and Purple Biotech
Given the investment horizon of 90 days Microsoft is expected to generate 0.21 times more return on investment than Purple Biotech. However, Microsoft is 4.74 times less risky than Purple Biotech. It trades about -0.04 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.03 per unit of risk. If you would invest 42,574 in Microsoft on August 28, 2024 and sell it today you would lose (695.00) from holding Microsoft or give up 1.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Microsoft vs. Purple Biotech
Performance |
| Timeline |
| Microsoft |
| Purple Biotech |
Microsoft and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Purple Biotech
The main advantage of trading using opposite Microsoft and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| Microsoft vs. GigaCloud Technology Class | Microsoft vs. Arqit Quantum | Microsoft vs. Cemtrex | Microsoft vs. Paysafe |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |